| SHORT COMMUNICATION
|Year : 1975 | Volume
| Issue : 4 | Page : 27-30
A double blind clinical study of prenylamine lactate in the cases of ischaemic heart disease
KC Kotia, Khalsa Amrit, Swaroop Dinesh, OP Garg, DS Pokharana
In the present double-blind trial, 25 cares received prenylamine and 26 cases placebo. The patients were observed for 6 weeks before institution of therapy and for another 6 weeks during therapy. Clinical as well as electrocardiographic assessment was done. There was improvement in frequency and severity of anginal attacks and the consumption of GTN tablets in both groups decreased. But this improvement was highly significant in prenylamine serieses compared to placebo. Electrocardiographic improvement was also more marked with prenylamine than with placebo. The side effects were even less marked in prenylamine series. Hence it is concluded that patients of angina pectoris are more benefitted with prenylamine than with placebo.
K C Kotia
Source of Support: None, Conflict of Interest: None